Indeed, the upregulation of stem cell markers upon functional BAP1 depletion is seen in human uveal melanoma and renal cell carcinoma, and is associated with aggressive cancer behaviour and poor patient outcome (Matatall et al., 2013; Peña-Llopis et al., 2012; Harbour et al., 2010). Here, BAP1 is linked to uveal melanoma.